Clinical trial
Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00124917 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00124917 |
|---|---|
| Title | Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer |
| Official title | A Phase I Study of Image Guided Dose Escalation With Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | Radiation |
| Enrollment | 6 |
| Start date | Jul 21, 2005 |
| Primary completion | Mar 6, 2011 |
| Completion | May 9, 2017 |
| First posted | Jul 28, 2005 |
| Last update posted | Sep 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: